We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

ECG-AI Algorithm to Aid Physicians in Earlier Identification of Cardiac Amyloidosis

By HospiMedica International staff writers
Posted on 19 Jul 2023
Print article
Image: Anumana’s cardiac amyloidosis algorithm has received Breakthrough Device Designation from the US FDA (Photo courtesy of Freepik)
Image: Anumana’s cardiac amyloidosis algorithm has received Breakthrough Device Designation from the US FDA (Photo courtesy of Freepik)

Cardiac amyloidosis is a severe, progressive, and often underdiagnosed rare disease leading to heart failure. In those affected, stiff heart walls hinder the left ventricle's function, disrupting proper blood flow in and out of the heart. Early diagnosis is crucial for timely interventions that can enhance patient outcomes. However, the disease's rarity, coupled with its nonspecific and varied symptoms such as shortness of breath, knee pain, bilateral carpal tunnel syndrome, kidney disease, and gastrointestinal issues, make early diagnosis challenging. While standard ECGs are usually obtained to assess these symptoms, human interpretation often overlooks subtle feature combinations that may signify cardiac amyloidosis. Now, an artificial intelligence electrocardiogram (AI-ECG) solution can detect patterns in ECG signals that are usually imperceptible to humans to provide an early warning for cardiac amyloidosis.

Anumana, Inc. (Cambridge, MA, USA) has developed an AI-ECG algorithm to facilitate the early detection of cardiac amyloidosis. The AI-powered software can interpret signals from ECGs that might be missed by human analysts. Given the widespread use of the non-invasive ECG test, AI-ECG algorithms have the potential to reach a larger patient population at an earlier stage. Anumana is presently working on transforming this algorithm into a Software-as-a-Medical-Device (SaMD), with an aim to integrate this solution seamlessly into existing clinical workflows. This AI-ECG solution has also received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA), ensuring patients and healthcare providers have timely access to this algorithm.

“The ubiquitous nature of the painless, non-invasive Electrophysiology tests gives ECG-AI algorithms the potential to reach a larger number of patients earlier, something clinicians have long hoped for,” said Venky Soundararajan, PhD, Co-founder, and Chief Scientific Officer of Anumana. “Receiving the FDA Breakthrough Device Designation for our Cardiac Amyloidosis ECG-AI Algorithm recognizes the significant potential of this tool to detect disease early.”

Related Links:
Anumana, Inc. 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
Ultrasound Doppler System
Doppler BT-200

Print article


Surgical Techniques

view channel
Image: The prototype pacemaker is made of a specially engineered membrane (Photo courtesy of University of Chicago)

Ultra-Thin, Light-Controlled Pacemaker Regulates Heartbeats

Millions of individuals depend on pacemakers, small yet vital devices that help maintain a regular heartbeat by regulating the heart's electrical impulses. To minimize complications, there is growing interest... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.